Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2018American Journal of TransplantationOpen Access

A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

SJStanley C. JordanJCJua ChoiOAOlivier Aubert

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jordan et al. (2018) studied this question.

synapsesocial.com/papers/6a98ddd252d74751e81ff105https://doi.org/10.1111/ajt.14767
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation2017 · 51 citations
  2. 2Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation2016 · 264 citations
  3. 3Delayed graft function: a dilemma in renal transplantation2005 · 79 citations
  4. 4Time Dependency of Factors Affecting Renal Allograft Survival2000 · 183 citations
  5. 5Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival2006 · 117 citations